Remove DEA Remove Legislation Remove Medical Evaluation
article thumbnail

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Both DOJ and HHS agreed to conduct a medical and scientific evaluation of CBD independent of marijuana in 2015.

article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

Numerous attempts to introduce legislation to relax the provisions that placed cannabis on Schedule I of the Controlled Substances Act [“CSA”] have been made beginning in 1981 [i]. Both paths are complex processes in which scientific, medical, policy and political forces have influence. This Bill also died in committee [ii].

Banking 45